The following years, many research reports consistently showed that the “AD profile” of increased CSF levels of T-tau and P-tau together with decreased Aβ42 had high sensitivity and specificity, both in the range of 85–90%, to identify AD dementia, for review see (Blennow and Hampel, 2003). This evidence concerns the gene MAPT and Alzheimer disease.